TQB3617

· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TQB3617, covering 2025-12-08 to 2025-12-08. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial of TQ05105 Tablets Combined With TQB3617 Capsules in the Treatment of Myelofibrosis (MF) [Phase 1, Phase 2]

See pricing